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Amygdalin is one of the earliest of plant products 
which have been used for cancer treatment. As far back 
as 2800 B.C. in the time of the Pen T'sao (Great Chinese 
Herbal) of ancient China these Prunus species and other 
amygdalin bearing plants have been in medical use (Halstead, 
1977). The precise mechanism of action of amygdalin is 
not known but several hypotheses have been proposed (Brekman 
and Dardymov, 1969; Krebs, 1970; Brewer and Passwater, 
1976). 
Amygdalin is a cyanogenic glycoside derived from 
the kernels of various fruits of the genus Prunus (synonym 
amygdalus). When amygdalin is hydrolyzed it yields glucose, 
benzaldehyde and hydrogen cyanide (Montgomery, 1969). 
Due to its plant origin, chemical composition and 
theoretical antineoplastic effects it has been attributed 
to a number of functions. It has been identified as a 
food product (Montgomery, 1969), a vitamin (Krebs, 1970), 
a cancer agent (Wodinsky and Swiniarski, 1975) and an 
analgesic (Halstead, 1977). The hydrogen cyanide released 
from amygdalin has been theorized as exerting selective 
anticancer effects by Ernst T. Krebs, Jr. in 1952. The 
1 
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release and specificity of cyanide is due to certain enzymes 
present in the body (Viehover and Mack, 1935). 
In the early 1900's Ernst T. Krebs, Sr., a physician 
and pharmacist, developed an apricot extract which contained 
enzymes with unusual biochemical properties. His 
experimentation with this extract on cancer tissue was 
later reported toxic and only partially effective (Culbert, 
1976). Krebs, Jr. followed his father's dedication to 
medicine and pharmacy. It was his reasearch into John 
Beard's Trophoblastic Thesis of Cancer that led him to 
the investigation of the effects of enzymes on cancer. 
Beard's theory (1902) pointed to the similar properties 
pregnancy trophoblast cells and cancer cells shared. He 
believed because of these similarities trophoblast cells 
and cancer cells were identical. From these observations, 
Krebs, Jr., Krebs, Sr. and H. Beard (1950) eventually 
proposed that it was the pancreatic enzymes which causes 
the destruction of the pregnancy trophoblast cells. This 
led Krebs, Jr. to investigate the use of enzymes against 
cancer. Krebs claimed to have had partial success using 
these enzymes but the enzymes alone lacked the effectiveness 
Beard claimed in his theory (Culbert, 1976). 
Krebs went back to his father's original apricot 
extract and subsequently claimed to have synthesized beta-
cyanophoric glucuronicide which in the presence of beta-
..... 
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glucuronidase he postulated it released hydrogen cyanide. 
This new compound was called Laetrile® for it was derived 
from a laevo-rotary nitrile. Cancer cells are rich in 
enzymes beta-glucosidase and beta-glucuronidase which split 
nitrilosides (organic compounds containing cyanide) and 
liberate hydrogen cyanide (Haisman and Knight, 1967~ Krebs, 
1967, 1970~ Culbert, 1974). Krebs indicated that localized 
high concentration of beta-glucuronidase present in cancer 
cells facilitated the selective release of hydrogen cyanide 
from Laetrile® at the cancer site which, in addition, is 
almost totally devoid of the enzyme ~hodanese which in 
normal body cells detoxifies cyanide to thiocyanate (Krebs, 
1970). Thus, the end result is the selective destruction 
of cancer cells. Although attractive Kreb's hypothesis 
about the mechanism of action of Laetrile® has not been 
confirmed for the most part. 
At present amygdalin is being used in cancer 
therapy. The main biochemical difference between it and 
Kreb's Laetrile® is that amygdalin contains 2 glucose 
molecules and Laetrile® has only 1. Hydrolysis of amygdalin 
by the enzyme beta-glucosidase to release hydrogen cyanide 
has been scientifically documented (Haisman and Knight, 
1967). Therefore the current use of amygdalin for cancer 
therapy is based upon the assumption of cyanide release 
by the enzyme beta-glucosidase (Griffin, 1974). 
The dosages of amygdalin found toxic to adult 
animals by researchers are not uniform. Amygdalin at 
dosages as high as 10 gm/kg body weight were found to be 
non-toxic to adult animals (Burk, 1971). On the other 
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hand, Amygdalin MF (McNaughton Foundation) was found to 
reduce the median survival time of mice 6-16% with dosages 
ranging from 50-500 mg/kg (Hill and Shine, 1975). Moreover, 
Krebs (1970) has indicated that Laetrile is non-toxic at 
dosages as high as 25,000 mg/kg body weight. In our 
laboratory toxicity studies with amygdalin which were 
performed in adult mice, at dosages ranging from 1000-2500 
mg/kg for 15 days, proved to be non-toxic (Manner, DiSanti 
and Michalsen, 1977). Hill et al (1976) found that 
amygdalin at a dose of 2000 mg/kg for 4 days caused a 5% 
death rate in adult mice. 
The question of the teratogenic potential of this 
controversial compound clearly warrants further 
investigation due to the increasing number of people who 
are choosing it for cancer therapy. Teratology is the 
scientific study of biological malformations produced during 
the development of the organism. Agents causing 
malformations to developing embryos when administered to 
mothers during their pregnancy are ordinarily harmless 
to the adult animals themselves. This is partially due 
to the fact the fetus does not have the detoxifying 
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capabilities of the adult organism {DiPaolo, 1969). The 
development of a sound technique for verification of the 
effects of these compounds on developing embryos has its 
limitations because different species have different levels 
of tolerances. A good example of this is the Thalidomide 
incident that took place in the 1960's. Early testing 
of this agent by Somers {1962), and Seller {1962) showed 
that malformations occurred in rabbits but none in the 
rat fetuses only reabsorptions were found, no external 
abnormalities. Later, it was also found to be teratogenic 
to man (Lenz, 1966). Additional testing of this drug 
eventually showed to be teratogenic in the rat {King, 1962). 
Thus, we cannot reliably utilize these data for a valid 
comparison between laboratory animals and humans {Wilson, 
1972). The animal studies are valuable for they give us 
a foundation on which to base further studies. These type 
of studies are the best available at the moment since human 
trials are not an acceptable alternative without having 
established some knowledge from prior animal testing 
{Murphy, 1965). 
Wilson {1965) additionally describes the 
complexities of these studies. They involve both non-
embryonic and embryonic factors. The non-embryonic factors 
are the physical environment of the embryo {maternal 
organism), the agents mechanism of action and the dosage 
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levels. The embryonic factors include the genotype of 
the species tested and the developmental stages at which 
the embryos are more susceptible to teratogenic actions. 
The degree of susceptibility varies greatly during the 
course of the animals gestational period. In the very 
early stages of the embryo's development when the dividing 
cells are totipotent, destruction of a certain percentage 
of these cells is not considered to be harmful. The embryo 
is able to make internal adjustments so growth and normal 
development may continue. The cleavage stage seems quite 
resistant to teratogens but only to a point. Once too 
• many of the totipotent cells have been damaged, the embryo 
can not recover. Teratogenic susceptibility is highest 
during the time the germ layers are formed (day 5 in the 
mouse and as early as the eleventh and twelfth day in 
humans). The highest incidence of malformations by a 
variety of teratogens may occur shortly after this time 
once localized areas acquire organ forming capabilities. 
At this time chemically differentiated cells may be subject 
to teratogenesis several hours or days before their role 
in development is indicated by morphological 
differentiation. As differentiation and organogenesis 
proceed the susceptibility of teratogenesis decreases. 
Larger doses of the teratogen are also required to produce 
similar malformations brought about earlier, and sometimes 
similar ones cannot be brought about at all. 
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This teratogenic study of amygdalin administered 
to pregnant mice is not designed to prove or disprove either 
Kreb's "cyanide theory" or Beard's Trophoblastic Thesis 
of Cancer. Since amygdalin is theorized to attack cancer 
cells, and since cancer cells are similar to trophoblast 
cells as Beard and Krebs believe then the possibility of 
trophoblastic damage by amygdalin administered to the 
pregnant female needs to be examined. In addition, this 
study is designed to evaluate if amygdalin is toxic to 
the developing embryo and fetus which may lead to abnormal 
development. Hopefully it will stimulate further studies, 
so its possible effects on human embryos and fetuses can 
be evaluated. 
REVIEW OF RELATED LITERATURE 
AMYGDALIN 
Amygdalin was one of the first isolated cyanogenic 
glycosides. A glycoside is any natural plant or animal 
compound that contains sugar. A cyanogenic glycoside is 
a compound containing sugar and having the capacity of 
producing cyanogen or hydrocyanic acid (Halstead, 1977). 
A list of the sources of cyanogenic glucosides (any 
glycoside whose sugar constituent is glucose) which are 
habitually consumed by man are cassava, sweet potato, yam, 
maize, millet, bamboo, sugar cane, peas, beans, and kernel 
of almond, lemon, lime, apple, pear, cherry, apricot, prune 
and plum as well as about 150 other foods (Halstead, 1977). 
Two French chemists, Robiquet and Boutron-Charland 
isolated crystalline amygdalin in 1830. The term amygdalin 
comes from the scientific name of the bitter almond ( 
Amygdalin communis amara) from which much of the substance 
is derived. The Merk Index (1976) describes amygdalin 
as D-mandelonitrile-B-D-glucosido-6-B-D-glucoside. The 
empirical formula is c20H27N11 and has a molecular weight 
of 457.42. Its elemental composition is C 52.51%, H 5.95%, 
8 
N 3.06% and 0 38.47%. The molecular structure can be seen 
in figure 1. As early as 1935 Viehoever and Mack (1935) 
demonostrated amygdalin's hydrolysis was possible by 2 
methods. One method, amygdalin is split by an emulsin 
which contains an enzyme that yields glucose and 
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mandelonitrile glucoside. ~hese are subsequently converted 
by an enzyme in the emulsin with the final end products 
being benzaldehyde, 2 glucose molecules and hydrogen 
cyanide. The other method is hydrolysis with hot dilute 
mineral acids giving the same end products as the first 
method. 
Amygdalin is often referred to by the term Laetrile 
however they are not chemically synonymous compounds. 
The term Laetrile derived from the chemical term laevo-
mandelo-nitrile was first proposed by Ernst T. Krebs, Jr. 
~1erck Index ( 1976) defines Laetrile® as 1-mandeloni trile-
a-glucuronic acid. Its empirical formula is C14H15N07 
and has a molecular weight of 309.27. It's elemental 
composition is C' 54.37%, H 4.89%, N 4.53% and 0 36.21%. 
The molecular structure is shown in figure 2. It may be 
I, '~ • 
obtained by either hydrolysis of amygdalin and oxidation 
of the resulting 1-mandelonitrile-B-glucoside with platinum 
black or by the condensation of mandelonitrile with glucose 
and subsequent oxidation; or by the condensation of 
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Jr. and Krebs, Sr. who obtained the pat. 778,855 in 1958 
for Laetrile® (Merk Index, 1976). Confusion arises because 
both these terms amygdalin and Laetrile are interchangeably 
used in literature. 
Ernst T. Krebs, Sr.'s extract of beta cyanogenic 
glucoside was used in cancer treatment back in 1920. Later 
in 1953 his son, Ernst T. Krebs, Jr. claimed he had 
synthesized a new Laetrile@ which he designated as beta-
cyanophoric-glucuroniside because in the presence of any 
enzyme beta-glucuronidase it released quantities of hydrogen 
cyanide. Since that time Krebs, Jr. has now designated 
the term Laetrile to refer to any beta-cyanogenic glucosides 
which includes amygdalin and any of its chemical derivatives 
(Halstead, 1977). 
PROPOSED MECHANISM OF ACTION OF AMYGDALIN 
In the early 1950's the mechanism of action of 
Amygdalin, often referred to as the "cyanide theory", was 
proposed by Ernst T. Krebs, Jr. His proposed mechanism 
of action is still questionable but some evidence 
substantiates certain aspects of his theory. He originally 
proposed that tumor tissue was high in the hydrolyzing 
enzyme of amygdalin, beta-glucuronidase. Data by Fishman 
and Anlyan (1947a,b) confirms its high concentration in 
tumor tissue. When Laetrile reached the site of the tumor 
12 
Krebs claimed that beta-glucuronidase cleaved the hydrogen 
cyanide and benzaldehyde from Laetrile thus exerting its 
antitumor effect (Krebs, 1970). The cyanide released in 
somatic cells of the body where low concentrations of beta-
glucuronidase are normally found is detoxified by large 
quantities of the enzyme rhodanese, so no damage to normal 
tissues would be expected to occur. The tumor cell 
according to Krebs is almost totally devoid of this enzyme 
so it does not detoxify the hydrogen cyanide at the tumor 
site. Thus, Laetrile can exert its selective anti-
neoplastic activity on cancer cells (Krebs, 1970). Krebs 
additionally indicates that the benzaldehyde released during 
hydrolysis of Laetrile in the presence of oxygen, is 
immediately oxidized to benzoic acid which is non-toxic. 
Because of Otto Warburg's (1966) demonstration of the 
suboxidative activity of cancer cells, which uses more 
fermentative metabolism than respiratory metabolism, Krebs 
felt that this reduced aerobic metabolism in cancer cells 
would slow down the oxidation of benzaldehyde to benzoic 
acid. Krebs proposed the benzaldehyde itself was a powerful 
cytotoxin to neoplastic cells. He proposed that a 
synergistic effect between the cyanide and benzaldehyde 
contributes to the poisoning of the cancer cells (Krebs, 
1970). 
Today amygdalin, as well as other natural 
nitrilosides, are widely used in cancer therapy. However, 
amygdalin has been shown to be hydrolyzed by the enzyme 
beta-glucosidase. Research by Haisman and Knight (1967) 
has confirmed the degradation of amygdalin in the presence 
of a beta-glucosidase preparation. The breakdown occurs 
in 3 steps. First the B-(1-6') bond of the gentiobiose 
portion (2 glucose molecules) of amygdalin was split to 
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yield D(-)mandelonitrile-B-glucoside (prunasin) and glucose. 
Second, the prunasin is hydrolyzed to (+)mandelonitirle 
and glucose. Third, the (+)mandelonitrile is broken down 
to benzaldehyde and hydrocyanic acid (see firgure 3). 
Because amygdalin had become the commonly used 
natural nitriloside, Krebs (1967) tried to clarify the 
confusion that often exists between the 2 hydrolyzing 
enzymes (beta-glucuronidase and beta-glucosidase) of these 
nitrilosides. 
Both enzymes are described generally as beta-
glycosidases. Synthetic glucuronosidic nitrilosides 
(Laetrile) have been synthesized to exploit the beta-
glucuronidase system in the same manner in which the 
natural nitrilosides are used against the beta-
glucosidase system at the malignant lesion. In 
comparative studies it has been found that both the 
natural and synthetic nitrilosides are active against 
their respective enzyme systems. 
Halstead (1977) and Greenberg (1975) both made 
reference to Kreb's proposed alteration to his old "cyanide 
theory" when amygdalin is ingested. According to Krebs 
AMYGDALIN 
H2o 1 (beta-glucosidase) 
MANDELONITRII.E-GLUCOSIDE + GUJCOSE 
{PRUNASJN) 
~0. {beta-glucosidase) 
MANDELONITRIIE + GIDCOSE 
Figure 3 
1 (hydroxyni trilase) 
HCN + BENZAI.JJEHYDE 




. amygdalin is hydrolyzed to mandelonitrile and it goes to 
the liver where it is changed to Mandelonitrile-glucuronide 
(Laetrile). Then, once in this form the enzyme beta-
glucuronidase is able to hydrolyze it, releasing the 
hydrogen cyanide when the glucuronide reaches the tumor 
site. 
Halstead (1977) states that Kreb's altered "cyanide 
theory" is theoretically possible and that the prunasin 
glucoside can be converted to Laetrile glucuronide but 
it requires a 2 step-oxidative process not yet 
experimentally demonstrated. There has been work done 
to show that glucuronide formation occurs in the liver 
and to a lesser extent in the intestines and kidneys (White, 
Handler and Smith, 1973). The required beta-glucuronidase 
required to convert the Laetrile glucuronide into hydrogen 
cyanide and benzaldehyde has been demonstrated to be present 
in cancerous tissue of the breast, uterus, stomach, 
mesentary, abdominal wall and esophagus at concentrations 
between 100-3600 times greater than in non-cancerous tissue 
(Fishman and Anlyan, 1947). 
BETA-GLUCURONIDASE 
Beta-glucuronidase (B-D-glucuronide gluronohydrolase 
EC 3.2.1.31) is a hydrolytic enzyme. It is located ·in 
the lysosome bodies of cells and it is widespread in animal 
tissues. It plays a role in the catabolism of 
mucopolysacharides (the carbohydrate-protein that forms 
ground substance) (Levvy and Marsh, 1960); it is also 
associated with an increase in cell proliferation (Kerr, 
campbell and Levvy, 1949) and tumor metabolism (Fishman, 
Baker and Borges, 1959). 
BETA-GLUCOSIDASE 
Beta-glucosidase (B-d-glucoside-glucohydrolase 
EC 3.2.1.21) is also a hydrolytic enzyme. It is found 
in varying amounts in animal tissue. A beta-glucosidase 
study on tumor and non-tumor bearing mice (Manner, 
Michaelsen and DiSanti, 1978) indicated that there was 
definitely a much higher concentration of beta-glucosidase 
in the mammary tumor and the liver of tumor and non-tumor 
bearing mice than in the brain and muscle tissue of both 
tumor and non-tumor bearing mice. It specifically 
hyrdolyzes the beta-D-glucoside linkage (Greenberg, 1975). 
RHODANESE 
Rhodanese (thiosulfate: cyanide sulfurtransferase 
EC 2.8.1.1) is a mitochondrial enzyme which catalyzes the 
formation of thiocyanate from thiosulfate and cyanide. 
The enzyme has the ability to neutralize hydrogen cyanide 
(Osuntokun, 1970; Montgomery, 1969 and Oke, 1969). There 




seen in figure 4 (Montgomery, 1969) (Oke, 1969). 
Thiosulfate in the body combines with the hydrogen cyanide 
and catalyzed by rhodanese to form thiocyanate and sulphite. 
This thiocyanate is excreted in the urine. Manhardt (1978) 
found that as increasing dosages of amygdalin beginning 
at 500 mg/kg and going as high as 5,000 mg/kg when injected 
intramuscularly into mice did increase the thiocyanate 
content in the urine. In the second pathway cyanogen reacts 
with 3-mercaptopyruvate aided by another sulfurtransferase 
to yield thiocyanate plus pyruvate. There is also some 
evidence that hydrocobalamin (vitamin B-12) may play a 
role in cyanide detoxification, for it is able to take 
up cyanide as cyanocobalamin. It has been shown that mice 
can be protected from cyanide poisoning with the 
administration of hydroxycobalamin (Mushett, et al 1952). 
Urinary thiocyanate excretion was found to be increased 
not only by the ingestion of cyanide but also by a vitamin 
B-12 deficiency (Montgomery, 1969). Compared to the liver, 
spleen and kidney cancer cells were found to have a lower 
concentration of rhodanese (Rosenthal, 1948; Westley, 1973). 
NATURE OF CANCER 
The mechanisms of cancer cells growth have been 
proposed by several scientists. Much of the early work 
is accredited to Otto Warburg, Nobel Prize winner in 
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3 
~igure 4 CN DETOXIFICATION BY RHODANESE 
transferring enzyme of cell respiration and voted a second 
Nobel Prize in 1944 for his discovery of the active groups 
of the hydrogen transferring enzymes. He has claimed to 
know the cause and prevention of cancer. Warburg (1966) 
summarized it by saying, 
the prime cause of cancer is the replacement of the 
respiration of oxygen in the normal body cells by a 
fermentation of sugar. All the normal body cells meet 
their energy needs by respiration of oxygen, whereas 
cancer cells meet their energy needs in a great part 
by fermentation. 
Warburg (1966) supported his theory by showing 
that when there was 35% inhibition of oxygen repiration 
this brought about the transformation of embryonic cells 
into tumor cells. He also preferred to designate tumor 
cells as "partial anaerobes" rather than "facultative 
anaerobes" because a body cell is tranformed into a tumor 
cell if only a part of the respiration is replaced by 
fermentation. Warburg attempted to explain the 
thermodynamics of the reduced respiration on cancer 
induction on the basis of dedifferentiation. He felt that 
during cancer development, when oxygen respiration falls, 
the highly differentiated cells are transformed to 
fermenting anaerobes which have lost all their body 
19 
functions and retain only their useless property of growth; 
thus they have dedifferentiated. Dedifferentiation provides 
no work, just a true equilibrium state. He explains this 
20 
difference between differentiation and dedifferentiation 
energy.with chemistry rather than physics. Both respiration 
energy and fermentation energy do their work through 
phosphate energy but the methods of phosphorylation are 
• 
different. He sees only oxidative phosphorylation as 
allowing differentiation whereas the fermentative 
phosphorylation is not able to do so. Only through the 
more complex pathways of respiration is the needed amount 
of energy for the differentiation of body cells attained. 
He believes a tumor by itself can never succeed in 
redifferentiating its dedifferentiated cells during the 
short duration of a human life. 
~nether description for cancer growth has been 
given the term "aerobic glycolysis" (Albert L. Lehninger, 
1975}. In it there exists an irregularity in the 
integration of glycolysis and the tricarboxylic acid cycle 
(respiration}. The result is that despite a similar oxygen 
consumption rate of cancer cells in relation to normal 
cells, cancer cells tend to utilize 5-10 times more glucose 
and convert most of it into lactic acid even though they 
have a nearly normal rate of respiration. This is called 
aerobic lactate production. This process normally occurs 
in a few tissues such as erythrocytes, skeletal and heart 
muscles when under heavy stress, and in the retina. The 
end result of this aerobic glycolysis which should normally 
, 
be anaeorbic is that in addition to the generation of ATP 
from respiration and oxidative phosphorylation there is 
also a large accumulation of ATP from glycolysis due to 
its increased rate. One of the most important effects 
on the body from this metabolic imbalance is the cancer 
cells utilization of large amounts of blood glucose with 
the release of large amounts of lactate into the blood 
from glycolysis. This lactate is then taken to the liver 
where reconversion to glucose occurs by the process of 
gluconeogenesis. The energy balance from the cancer cells 
metabolism thus is one of a disadvantage to the host. 
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The formation of one molecule of glucose from lactate 
requires the input of 6 molecules of ATP whereas the cancer 
cell obtains only 2 molecules of ATP per molecule of glucose 
converted to lactate in glycolysis. Large masses of cancer 
cells can be quite a metabolic drain on the host, and can 
be best described as metabolic parasites. 
CYANIDE VS. CANCER 
There are theories proposed which attempt to 
directly link the function of amygdalin to the destruction 
of cancer cells. One theory is that by Mark McCarty (1975). 
He describes amygdalin as possessing the capability of 
producing a serum cyanide which could cause selective 
toxicity to cancer cells without injury to the host. This 
mechanism involves the acidification of cancer tissue and 
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the decrease of glucose available to the tumor regions 
with poor links to the circulatory system. Cyanide 
activated acidification is suppose to activate the immune 
system so it helps slow down, stop or even reverse tumor 
growth. McCarty's explanation helps explain why tumor 
experiments performed in test tubes would not be selectively 
sensitive to cyanide while tumors in vivo do show 
sensitivity due to the presence of an immune system. 
Brewer and Passwater (1976) have explained how, 
through the presence of hydrogen cyanide and adequate 
potassium levels, the cancer process within cells may occur. 
As cancer causing agents (carcinogens) attach to cell 
membranes, they eliminate or decrease the transport of 
oxygen across the membranes. This causes the fermentation 
of glucose to lactic acid and, as a result, a drop in the 
hydrogen ion concentration from 7.35 to 6. Lysosomal 
enzymes are released within the cell as a consequence of 
the foregoing. The reaction of the lactic acid and 
lysosomal enzymes with the cells DNA, destroy the normal 
DNA-RNA processes and regulatory mechanisms of the cell. 
Thus, one means of dealing with the abnormal r.ellular 
processes of cancer may be by first finding a method of 
raising the pH level to 9. A theoretical method of doing 
this is by feeding the host a suitable nitrile (amygdalin) 
which will hydrolyze in an acid medium to release hydrogen 
cyanide within that cell followed by the administration 
of cesium or rubidium salts which along with potassium 
constitute the cell membrance transportation carriers of 
oxygen. The hydrogen cyanide at the cell membrane makes 
it very pervius to potassium, cesium and rubidium ions. 
The concentration of the latter within the cancer cells 
where hydrogen cyanide is found should raise the pH level 
to 9. As a result of this, cancerous activity should 
decrease allowing the toxic enzymes in the inner layers 
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of cells in the tumor to bring about the death of the cancer 
cells when their proliferation has stopped. Here the 
amygdalin's hydrogen cyanide is not directly involved in 
attacking the cancer cells themselves but rather it serves 
as a catalyst for the chemical reactions that slow down 
cancer growth. 
Research reported by Lea, Koch and Morris (1975} 
have shown that sodium cyanate at a dose level of 125 or 
250 mg/kg i.p. causes an inhibition of the incorporation 
of labeled amino acids into cytoplasmic and nuclear proteins 
of various heptomas (tumor of the liver}. However, in 
the livers of rats bearing these tumors there was no 
inhibitory effect on the incorporation of labeled amino 
acids into protein. These studies indicate that a greater 
than 85% inhibition of amino acid incorporation could be 
brought about with sodium cyanate in hepatoma 5123C, 
hepatoma 9618Azand the MK3 kidney tumor whereas there was 
little or no effect on the kidney, liver, brain, skeletal 
muscle, intestinal mucosa and regenerating liver (after 
partial hepatectomy) of those animals bearing tumors. 
Another hypothesis has been proposed by Brekhman 
and Dardymov (1969). It deals with adaptogens which they 
say increase the nonspecific resistance of the host. 
"Adaptogens are substances that are able to bring on a 
normalizing effect within the host's general resistance 
to disease". They found that certain plant glycosides 
have the ability to increase the overall immune mechanism 
of the body to such degenerative diseases as cancer and 
atherosclerosis. They believe the adaptogens may function 
by stimulating the production of immune bodies and involve 
the biosynthesis of protein and influence nucleic acid 
metabolism. 
Oke (1969) indicates that cyanide in the body has 
an affinity for metal ions such as copper. It is able 
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to combine with haemoglobin to form cyanohaemoglobin which 
is not an oxygen carrier. Also there is the reversible 
combination with the copper of the cytochrome oxidase which 
thereby inhibits its function as an oxidative enzyme in 




Different amounts of foods, poisons and drugs are 
required in order for some type of effect to take place. 
The correct dose of each is what differentiates a poison 
from a medicinal dose. Amygdalin is no different and its 
toxic effects are partially governed by dose and method 
of route of administration (Halstead, 1977). 
There has been discrepancy in the results obtained 
from the toxicity studies of amygdalin. Beginning with 
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the raw almond kernel itself, Trube-Becker (1965) estimated 
that 50-70 nuts would have to be eaten to provide a lethal 
dose to adults and as few as 7-10 almonds for a child. 
He indicated that these numbers may vary since the amygdalin 
content diminishes during prolonged periods of storage, 
and simultaneous ingestion of sugar decreases their toxic 
effect. Auld (1912-1913) has suggested that beta-
glucosidase is inactive at the pH of human saliva or of 
gastric juice and was also inactiviated by the presence 
of cellulose or glucose. The latter could explain Trube-
Becker•s finding of decreased toxicity of ingested amygdalin 
with sugar. Reports confirming these oral toxicity findings 
have been found when there was accidental ingestion of 
too many kernels (McTaggarts, 1936). 
Auld (1912-1913) has shown guinea pigs fed amygdalin 
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in amounts up to twelve lethal doses of hydrogen cyanide 
per day showed no ill effect. Another study reported by 
the Cancer Commission of the California Medical Association 
(1953) showed that amygdalin that was given by stomach 
tube to mice was found safe at doses below 300 mg/kg but 
once 400 mg/kg and higher doses were administered death 
occurred in a matter of minutes to one hour. Dr. Navarro, 
(1959) who uses amygdalin therapy on cancer patients, 
suggests that amygdalin is hydrolyzed by the hydrochloric 
acid in the stomach and should never be given by mouth 
(Lewis, 1977). Other routes of administration have proven 
~ 
to be far less toxic. In animals given intravenous doses 
in excess of 100 times the intravenous dose given to humans, 
amygdalin proved non-toxic. Conversely, the oral toxicity 
of the compound was found to be 39 to 44 times greater 
than the intramuscular route (Halstead, 1977). 
In human cancer therapy, amygdalin has been 
administered in dosages up to 70 gms in adult humans by 
combined oral and parenteral routes without ill-effects 
(Rubin, 1977). Lewis (1977), however disagrees with Rubin's 
findings, and he indicates that 3 grams of amygdalin 
contains 180 mg of cyanide and that 200 mg of cyanide are 
toxic to humans. 
Hill et al (1976) found that mice receiving 
intraperitoneal (i.p.) injections of amygdalin in dosages 
,. 
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ranging from 50-500 mg/kg for 4 days showed no toxic effects 
but higher doses of 2000 mg/kg for 4 days caused a 5% death 
rate. In a study by Browne (1974), intravenous injections 
of 500·mg of amygdalin on alternate days for a total of 
6 injections caused remission of thyroid carcinoma in dogs. 
Campbell (1974) gave no indication of toxic results when 
he injected albino mice with 1000 rng/kg i.p. injections 
for 10 days. In ou~ labcratory toxicity studies with 
amygdalin administered to JaxC57BL/KsJ mice and dosages 
ranging from 1000-2500 mg/kg for 15 days intramuscularly, 
proved to be non-toxic to the adult mice (Manner, DiSanti 
and Michalsen, 1977). Other experiments have confirmed 
such non-toxicity of amygdalin administered at high dosages 
and Burk (1971) found that unhydrolyzed amygdalin is non-
toxic to all animals studied. He found that dosages up 
to 5-10 gr/kg by various routes of administration were 
non-toxic, and he also found that concentrations of either 
cyanide alone or benzaldehyde alone were far less effective 
in killing or metabolically disturbing Erlich ascite 
cells in vitro than equivalent concentrations of amygdalin 
plus a small amount of beta-glucosidase. 
The amygdalin used is normally laevo-rotary. When 
the racemic form, designated as Amygdalin MF (NSC 1578) 
has been used, different results have been obtained. In 
a study by Wodinsky and Swiniarski (1975), Amygdalin MF 
used at dose levels as high as 800 mg/kg administered i.p. 
to mice for 9 days showed no toxic effects. Early deaths 
were noted, however, when 10 mg/kg of beta-glucosidase 
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was injected i.p. one-half hour prior to 100 mg/kg of 
Amygdalin MF. Beta-glucosidase was found to be non-toxic 
by itself at doses as high as 10 mg/kg. Results from a 
similar study by Laster and Schabel (1975) using Amygdalin 
MF, found that when amygdalin MF was administered without 
beta-glucosidase 10% deaths were produced at a dose of 
500 mg/kg, 30% deaths occurred at 335 mg/kg and no deaths 
occurred at 220 mg/kg for 9 days. When beta-glucosidase 
at 10 mg/kg dose was administered simultaneously with 
Amygdalin MF the highest level of Amygdalin MF that they 
found that could be given without exceeding the LDlO in 
normal mice was 53 mg/kg dose. 
An in vitro study by Levi et al (1965) was based 
upon incubation of surviving tumor tissue slices or cell 
suspensions in Warburg Manometric vessels in the presence 
of radioactive tracers. During incubation tumor respiration 
and glycolysis was measured. After incubation, tissu~ 
was assayed for the incorporation of the tracers. Two 
types of amygdalin were used in this experiment (United 
States and Canadian brands). When these compounds were 
analyzed both contained amygdalin but the Canadian type 
also contained .5% phenol whereas the u.s. brand contained 
sucrose and isopropylammonium iodide. The results of this 
study demonstrated that dosages of 4mM of both amygdalins 
had no significant effect on respiration of the cancer 
cells; however NaCN at much lower concentrations (.lmM) 
almost completely inhibited respiration of the human 
adenocarcinoma. NaCN also changed aerobic glycolysis of 
the tumor cells to anaerobic pathways. The effects of 
amygdalin on protein, RNA and DNA synthesis determined 
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by labeled amino acids, showed that except for inhibition 
of DNA synthesis by amygdalin (Can.), there were no other 
effects. NaCN, aerobically in the absence of glucose, 
completely inhibited all three syntheses in the tumor cells. 
Such inhibition was not seen, aerobically and anaerobically, 
when NaCN was added to vessels containing glucose. 
Apparently the NaCN inhibitory effect on respiration was 
overcome by the increase in aeorbic glycolysis when glucose 
was present. 
Krantz et al (1936) found that i.p. injections 
of potassium cyanide showed no growth inhibition or tendency 
to regress the Walker rat sarcoma 319. Perry (1935) showed 
that prolonged inhalation of cyanide arrested body growth 
in young rats and retarded the growth of Jensen sarcoma 
implants. Both r~gressing and growing tumors in treated 
animals had little capacity for transplantation. The range 
of the effective dose was limited and too close to the 
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lethal dose to be practical. 
TROPHOBLASTIC THEORY 
Ernst T. Krebs, Jr. owes much of his background 
for the development of his Laetrile~ to the Scottish 
embryologist by the name of John Beard (1858-1924). Beard 
published his findings in the British Jounral Lancet under 
the title of "Embryological Aspects and Etiology of Cancer" 
(1902). Later on in 1911 he published a book entitled 
"The Enzymes Treatment of Cancer and Its Scientific Basis". 
Beard's study was based on a trophoblast cell. This cell, 
first identified in 1857 and then named in 1876, was found 
to play a specific role in pregnancy. This trophoblast, 
regarded by some as an extraembryonic ectoderm of the 
embryo, spreads and multiplies rapidly appearing to eat 
its way into the uterus wall preparing a place where the 
embryo can attach itself for maternal protection and 
nourishment. For these and other characteristics, John 
Beard, Krebs, Sr. and Jr. and H. Beard believed that 
trophoblast cells and cancer cells were identical. A new 
title was later given for John Beard's study, "The Unitarian 
or Trophoblastic Thesis of Cancer" (Krebs, Jr., Krebs, 
Sr. and H. Beard, 1950). 
H. Beard (1958) described John Beard's concept 
of trophoblast and cancer cells development. It begins 
31 
with the union of the egg and sperm to form the zygote, 
which is the origin of asexual trophoblast and the germinal 
tract along which the primitive germ cell develops. The 
trophoblast undergoes mitosis at once while the primitive 
germ cell does not begin to divide until later. There 
was first to be the development of 35 trophoblast cells 
before the primitive germ cell begins to divide. This 
he felt accounted for the rapid development of the 
trophoblastic tissue (the asexual generation having no 
sex organs) in early pregnancy. Later, the primitive germ 
cells would divide by 7 mitosises, giving a potential female 
embryo an additional division or 256 primary daughter germ 
cells. One of these germ cells will go on to develop into 
the embryo (the sexual generation possessing sex organs) 
and the rest would migrate into the embryo, most reaching 
their destiny in the gonads but 20% never arriving there 
but landing in ectopic sites (abnormal positions) in the 
body which later on could develop into benign or malignant 
tumors. What determines the type of tumor is pure chance. 
The ectopic germ cell, having a embryonic destiny begins 
to develop asexually becoming an embyrona, asexual twin 
or benign tumor. If the embryonic stage is skipped then 
the ectopic germ cell is forced by an excess of the female 
sex hormones to start the process of meiosis. The resulting 
haploid gametogenous cell either dies or it is changed 
into the ectopic trophoblast cell which forms the malignant 
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tumor (Beard, 1958). 
What had puzzled John Beard is why the trophoblast 
eventually would be destroyed in normal pregnancy but cancer 
cells were not. The answer he found was that on the 56th 
day of pregnancy the cellular trophoblast begins to 
deteriorate and it is on this same day that the fetal 
pancreas begins its secretory function. The pancreas is 
the site of the inactivated (zymogens) pancreatic enzymes. 
Upon activation the enzymes get into the bloodstream and 
when they accumulate in sufficient quantities at the 
trophoblast, they eat away and digest these cells (Griffin, 
1974). 
BOVING'S BIOLOGY OF THE TROPHOBLAST 
Bent Boving (1960) explained his ideas on the 
biology of the trophoblast. He indicates that the 
trophoblast structure is not solely restricted to mammals, 
but that eggs of lower vertebrates show trophoblast-like 
behavior mostly of a nutritive and anchoring function. 
The nutritive property is primitive in the trophoblast 
whereas its invasive property found in mammals (but not 
all) is not a general property; it is more a comparatively 
late elaboration with many variations in anatomical detail. 
He feels the invasiveness is not so much a basic 
characteristic of an undifferentiated tissue as it is just 
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one of the many specializations of structure and function 
that a particular undifferentiated tissue may acquire and 
later on lose. The idea that the invasive property of 
the trophoblast is turned on then off is too simple. Boving 
(1960) has seen evidence of a human conceptus 11 days old 
that had passed through epithelium 5 days earlier and 
presumably injured it so that now it was in direct contact 
with the trophoblast. The trophoblast was separating the 
conceptus from the blood supply and the epithelium was 
not only surviving but healed the breach. Adjacent 
trophoblast tissue was still growing and could be seen 
engulfing a maternal vessel. He speaks only briefly about 
the similarities between trophoblasts and cancer cells. 
He feels the proof thus far available has not satisfied 
what he calls the "logical requirements for avoiding a 
mistaken conclusion". He will continue to feel this way 
as long as clinicians and pathologists can distinguish 
pregnancy from cancer and as long as cancer and pregnancy 
can coexist in one patient yet progress to different fates. 
Boving further suggests what he believes is the 
mechanism of trophoblastic invasion after anatomical 
analysis of a rabbit trophoblast. The abembryonic rabbit 
trophoblast invasion at the antimesometrial uterine 
epithelium appears to be brought about locally by contact 
and by what Boving described as a trophoblast knob 
\ 
(aggregates of trophoblastic syncytium forming slight 
projections and a pointed shape) and uterine epithelium 
with a vessel below. The invasion may be brought about 
at this site by a chemical produced in the blastocyst and 
transferred to maternal circulation. Boving feels it is 
not locally promoted by products secreted or stored in 
the endometrium. 
Boving (1960) condensed the invasive mechanism 
of an abembryonic rabbit trophoblast into the following 
hypothesis. 
One or two days before implantation, blastocyst 
metabolism increases so greatly that the previously 
adequate respiratory mechansisms become insufficient. 
Glycolysis relieves some of the energy needs, but 
metabolic wastes are produced faster than ever, and 
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some accumulates as bicarbonate thanks to a buffer 
system. As the time of implantation nears, progesterone 
augments endometrial carbonic anyhydrase and there 
by indirectly accelerates the removal of the accumulated 
bicarbonate by speeding carbon dioxide "blow off" from 
carbonic acid within the epithelial cell. As the carbon 
dioxide is carried off by maternal circulation at the 
base of the cell, alkaline products are left behind. 
The consequent local pH rise causes disaggregation 
of· epithelial cells in which it occurs, while the 
adjacent trophoblast, being synctial, remains intact 
and thus replaces the epithelim. 
Boving' (1960) warns that this hypothesis cannot be 
generalized for all invasions because anatomy of 
placentation varies in mammals, endometrial carbonic 
anyhydrases occurrences are variable and most invasive 
tumors are cellular, not synctial. Boving therefore makes 
no attempt to pinpoint the specific relationship of cancer 
cells and trophoblasts but only to bring about questions 
35 
of their relatedness. He feels that the high metabolic 
rates, glycolytic abilities and respiration insufficencies 
are probably a characteristic of both cancer and rabbit 
blastocyst. If this metabolism plus compensatory pH 
regulation by an alkali reserve are responsible for rabbit 
trophoblast invasion, it is possible, he believes, that 
these similar chemical mechanisms could work on cancer 
cells. He feels that the difference in the two could be 
that respiratory insufficiency of cancer cells is permanent, 
intrinsic and not subject to external control, whereas 
the trophoblast respiratory inadequacy is temporary, 
extrinsiic, and believed to be relieved by the trophoblast's 
normal physiological objective that of the maternal 
circulation. 
CANCER AND EMBRYONIC CELLS. 
Trophoblast and cancer cells share in the production 
of chorionic gonadotropin hormones (CGH). Evidence of 
CGH in urine of cancer victims goes back many years (Krebs, 
1946). In 1971, Li Reports that the syncytotrophoblastic 
cells are a source of chorionic gonadotropin secretion • 
. A small choriocarcinoma was found capable of secreting 
10 times or more the maximum amount of chorionic 
gonadotropin produced during a normal single pregnancy. 
The amount present indicates only the presence of tumor 
and does not reflect its total mass but does correlate 
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with the observable changes in the tumor growth (Li, 1971). 
Teratomas are congential tumors containing embryonic 
elements of all 3 primary germ layers. The most widely 
accepted theory as to their origins is that they are derived 
from diploid germ cells (Stevens, 1964, 1967). Evidence 
such as teratom~s·being more common in gonads than any 
other site is one of the several facts about them that 
confirms this theory. Li (1971) defines the trophoblastic 
diseases as chorionic tumors that may originate either 
from the placenta or from the germinal cells of the gonads 
of both sexes. 
Micaletti (1977) demonstrated that amygdalin had 
a definite effect on undifferentiated embryonic-like 
blastema cells of regenerating limbs on salamanders. After· 
the right forelimb of salamanders were amputated the animals 
were injected daily for 15 days with 2000 mg/kg of 
amygdalin. There was no difference found in the thickness 
of the regenerated epidermis (non-embryonic) in the control 
and treated groups. However, the pluripotential fibroblasts 
were significantly inhibited in the treated group. Blastema 
cells of the experimental group developed to a mean length 




Teratological studies examine the possible adverse 
effects of the enviro9ment on developing systems of germ 
cells, embryos, fetuses and immature postnatal individuals. 
This environment of the embryo or fetus is everything 
outside its skin such as the surrounding membranes, oxygen, 
nutrients or foreign chemicals. 
The following information is reported by Wilson 
(1973). The three main aspects that must be considered 
in the teratological study are causes, mechanisms and 
manifestations. Causes are the action by an agent from 
the environment on germ cells, embryos or fetuses. The 
agents may be radiation, chemicals, dietary imbalance, 
infection, hypoxia, temperature extremes, metabolic or 
endocrine imbalance, physical trauma and placental failure. 
One of these or a combination of them may produce the 
mechanism which occurs within the germ cells, embryos or 
fetuses producing mutations, chromosomal nondisjunction, 
mitotic interference, altered nucleic acid integrity or 
function, lack of precursors or substrates, altered energy 
sources, changed membrane characteristics, fluid-osmoylte 
imbalance and enzyme inhibition. These may lead to 
manifestations of pathogenesis initiated by one or more 
of the following: cell death where there are too few cells 
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to carry out morphogenesis or functional maturation; failed 
cell interaction where there is insufficent growth or 
activity of inductor tissue or lack of competence of induced 
tissue; reduced biosynthesis caused by inhibition of nucleic 
acid, protein or mucopolysaccharide synthesis; impeded 
morphogenetic movement where obstruction of cell migration 
or interference with invagination; tissue disruption caused 
by pressure, trauma or vascular stasis and altered 
differentiation schedule where the differentiation and/or 
growth are slowed down. The final result of one or more 
of these is intrauterine death, malformation, growth 
retardaton or functional deficit. There is a degree of 
vulnerability to these induced developmental deviations 
but experimental studies in animals have clearly shown 
that the greater danger is associated with a relatively 
short period of critical embryogenesis between germ layer 
differentiation (gastrulation) and completion of major 
organ formation. It is felt that the period beginning 
from fertilization through cleavage, blastocyst and early 
germ layer stages is the least susceptible to teratogenesis 
but appreciable lethality may occur. This is followed 
by the period of highest susceptibility to teratogenesis, 
that of differentiation and early organogenesis. 
Significant embryo death can occur at this time if doses 
are high enough. As organogenesis advances in the later 
part of the embryonic period the occurrence of teratogenesis 
and death decline greatly. There must be a significant 
elevation in dose if teratogenicity or lethality is to 
occur at all. Organogenesis is when the major processes 
within the embryo are differentiation, mobilization and 
organization of cell and tissue groups into organs. 
Interference at this time by teratogens causes gross 
structural defects usually malformations. Histogenesis 
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is characterized by successive cellular and tissue 
specialization which convert the primordial organs into 
definitive one. At this time functional maturation aiso 
begins, and both of these now continue throughout the fetal 
period progressing toward the size and proportions typical 
of the newborn. Interference during this period is expected 
to result in growth retardation and functional disturbances. 
Experimentally, these observations h~ve been demonstrated 
with a variety of agents, such as irradiation (Wilson, 
1954), maternal vitamin deficiencies (Warkany, 1954), drugs 
such as cortisone (Franser and Fainstat, 1951), and vitamin 
excess (Cohlan, 1954). They have all shown to produce 
their most severe teratogenic effects at specific times 
during gestation as well as specific types of developmental 
disturbances. That gestational period that has been found 
to have the maximum frequency of response to the teratogen 
is referred to as the critical period. 
DiPaolo (1969) indicates four requirements that 
must be considered for experimental teratogenic studies; 
the method of administration of a specific treatment, the 
dose, the use of the genetically susceptible animal, and 
knowledge of when the embryos are in susceptible stage 
of development (DiPaolo, 1969). The dosages used in any 
teratogenic study are dependent upon potency and duration 
of the treatment. There seems to be ample experimental 
support for the belief that teratogenic and embryo-lethal 
substances can be shown to have a threshold below which 
adverse effects are not found (Wilson, 1973). Karnofsky 
(1965) has found that most if not all drugs and chemicals 
can be shown to produce some type of embryo toxicity if 
applied in sufficent dosage during an appropriate time 
in embryogenesis in one or more species of animals. The 
beginning dosage should begin at or above the highest 
anticipated therapeutic level and should increase until 
40 
the threshold of embryo toxicity in appropriate test animals 
is found (Wilson, 1973). There are several acceptable 
methods of administration of the agent and each has their 
own advantages and disadvantages. The route chosen is 
usually the one that would be used clinically (Wilson; 
1973). 
The choice of test animals to be used in a 
teratogenic study is still debatable. It is generally 
accepted that no animal test will provide complete assurance 
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in the prediction of human teratologic risk. The ideal 
test animal should have the -following characteristics: 
absorb, metabolize and eliminate the tested agent in the 
same way as humans do, transmit this agent and its 
metabolite across the placenta at the same rate as in humans 
and have embyros and fetuses that have developmental 
schedules and metabolic pathways similar to humans. There 
is no presently used species, even the simian primates, 
that meet these requirements, in all respects (Wilson, 
1973). 
USE OF THE MOUSE 
The small size of mice does make it difficult to 
examine fetuses for defects. Their sometimes erratic 
breeding behavior and the high and occasionally variable 
rates of background malformation and intrauterine death 
in several inbread species are disadvantages in using the 
mouse in teratological studies (Wilson, 1973). However 
their advantages include low cost, small size (minimizing 
care and space) and the large amount of information known 
on their genetics, their physiology as well as their 
embryologic development (Dagg, 1963). The genetics of 
the mouse is better known than that of any other mammalian 
species (Grunberg, 1952, 1963). It has been shown that 
frequencies of malformation development due to a teratogen 
will vary among different strains of inbred mice. Inbred 
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strains (mating brothers and sisters for many years) develop 
homozygous stock that makes for good genetic uniformity 
but they may become resistant to teratogenesis by some 
agents (Wilson, 1973). Conversely, mice are known to 
respond readily to substances that have limited 
teratogenicity in other animals, for example, cortisone 
and the herbicide 2,4,5-T (wilson, 1973) earning them a 
justified reputation for unusual sensitivity. 
PLACENTAL DEFENSES 
Wilson (1973) feels that chemical agents used in 
teratology probably always are able to reach germ cells, 
embryos and fetuses in some fraction of their concentration. 
The determining factor for abnormal development would depend 
on whether a critical dosage reaches or accumulates in 
the developing organism. Catabolic breakdown, excretion, 
protein binding and tissue storage normally reduce the 
concentration of foreign chemicals in the maternal 
bloodstream decreasing the amount reaching the conceptus. 
In a study by Juhasz (1976) on the passage of LAS (linear 
.alkylbenzene sulfonate) across the teleost and mouse 
placenta, she found LAS to reach the embryo. However, 
through the use of liquid scintillation spectrophotometry 
more radioactive LAS was found in the zebra fish than the 
fat head minnow. An explanation offered was that the fat 
head minnow has a longer development time and maybe a slower 
metabolism. Data indicated that the LAS also passed into 
the mouse embryo after intraperitoneal injections. 
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Villee (1967) is of the opinion that the placenta 
should not be regarded as a barrier in the sense of being 
impervious because it probably does not absolutely exclude 
any chemical agent. However, the placenta is able to offer 
some chemical agent concentration reduction for the embryo 
or fetus. Rodents all possess a specialized placental 
structure called inverted yolksac placentae. Embryos of 
these species may be dependent on this atypical structure 
for nourishment during the critical first few days of 
organogenesis. It has been shown to be structurally and 
functionally different from the typical chorioallantoic 
placenta that is found in other mammals, (Everett, 1935; 
Padykula et al, 1966; Becket all, 1967 and Brent, 1971). 
Experiments using rodents have shown indications of embryo 
toxic effects at lower doses than those seen in monkeys 
(Wilson, 1971). Thalidomide was one of the shocking 
exceptions to the rule. Wilson (1972) reviewing 
teratological studies using non-human primates saw that 
primates showed little or no teratogenic effect to many 
chemical agents that are highly teratogenic to rats, mice 
and rabbits. 
44 
TERATOGENIC STUDIES OF AMYDGALIN 
Kreb's "cyanide theory" regarding amygdalin's 
specificity for cancer cells and the similarities found 
between trophoblast and cancer cells, warrant an 
investigation into the effects that amygdalin may have 
on implantation of the mammalian embryo and the general 
toxic effects it may have on the fetuses. Only one 
reference to such studies has been mentioned in passing 
in an editorial article on Laetrile in the "Western Journal 
of Medicine" (Lewis, 1977). Lewis makes reference to a 
teratological study of Laetrile by the McNaughton Foundation 
in their 1970 IND (investigational new drug application). 
The investigation was performed on pregnant rats fed 5 
or 25 mg/kg body weight per day of amygdalin. The control 
group had one fetus with a kidney abnormality and the 25 
mg group had 2 fetuses with kidney abnormalities. One 
fetus in the 5 mg group was also found to be hydrocephalus. 
However no mention was given to the total number of fetuses 
examined or when and how long the animals were treated. 
MATERIALS AND METHODS 
GENERAL PROCEDURES 
Jax C57BL/KsJ 6 week old virgin mice, Mus musculus, 
were obtained from Jackson Laboratories, Bar Harbor, Maine. 
The mice were at least 10 weeks old before being used in 
the experiments. Prior to experimentation, the mice were 
housed 4-6 in a cage (plastic shoe-box type) containing 
inert bedding (Sanicel). The mice were fed Purina Mouse 
Chow and given tap water ad libitum. Water bottles were 
checked daily and cages changed routinely. The room in 
which the mice were kept before and during experimentation 
was temperature-controlled and on a 12 and 12 hour light 
and dark cycle. 
Breeding was initiated by exposing female mice 
to male mice of the same strain in a 3-4 to 1 ratio. The 
presence of a vaginal plug was the criteria that mating 
took place and this was designated as day one of her 
gestational period. Females were randomly assigned to 
• 
the control or treated groups at the time the plug was 
detected. Each mated female was placed separately in her 




before. Treatments began on the first day and were 
continued everyday throughout pregnancy. 
PHASE I - NATAL STUDY 
The control group received .3cc of isotonic Lockes 
solution injected intramuscularly into the rear thigh. 
The treated group received .3cc of amygdalin in the same 
manner as the control animals. This dose of amygdalin 
was based on a 30 gram mouse and was equivalent to a 500 
mg/kg body weight dose. 
500 mg amygdalin 
1 kg body wt. 
= X mg amygdalin 
.03 kg mouse 
X = 15 mg amygdalin/injection 
= .015 gm amygdalin/injection 
.Ql5gm amygdalin/injection 
.3cc injection volume 
X = 1.5 gm amygdalin 
= X gm amygdalin 
30 cc H2o (distilled-deionized) 
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Thus, 1.5 gm amygdalin were dissolved in 30 cc of distilled-
deionized water and .3cc was equivalent to a 500 mg/kg 
dose. Amygdalin solutions were prepared fresh daily. 
This dose is 2-3 times greater than that received by 
patients on amygdalin therapy. This dose was also found 
to be non-toxic to the Jax C57Bl/KsJ mouse when administered 
intramuscularly (Manner, DiSanti and Michalsen, 1977). 
The amygdalin was obtained from Sigma Chemical Co., St. 
Louis, Missouri. 
Both groups of animals were weighed daily to 
determine if the mice did become pregnant and to note any 
sudden decrease in weight which may indicate embryonic 
reabsorptions. Both groups were allowed to carry their 
pregnancy full term and after delivery that same day, the 
newborn pups were collected and the litters weighed. An 
average weight for each pup was calculated. Each pup was 
then sexed and examined for external abnormalities. Sex 
differentiation was based on the knowledge the anus and 
clitoris are roughly one-half to two thirds as far apart 
as the anus and the penis in newborn mice. The litters 
were then each divided in half. One half was stored in 
vials of Bouin's Fixative (Humason, 1962) for 2 weeks and 
sectioned according to Wilson (1965). 
BODIN'S FIXATIVE (Humason, 1962) 
Picric acid, saturated aqueous •••••••••• 75.0 ml 
Formalin................................ 25.0 ml 
Glacial acetic acid..................... 5.0 ml 
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The pups were sectioned by hand with a razor blade into 
1-1.5 m~ thick sections that began at the nose and continued 
through most of the length of the body in this fashion. 
The other half of the litter was placed in 95% ethanol, 
cleared and stained with Alizarin Red according to Gurr 
(1953). Bone staining with this technique resulted in 
red-stained bones in contrast to the unstained transparent 
soft surrounding tissue. 
ALIZARIN RED TECHNIQUE (Gurr, 1953) 
For bone staining in small vertebrates (Dawson's method) 
Solutions required: 
A. Potass. hydroxide 1% acqueous 
B. Alizarin Red, s ......................... 0.1 gm 
Po tass. hydroxide. • • • • • • • • • • • • • • • • • • • • • • 10 gm 
Distilled water •••••••••••••••••••.••••• 1 liter 
C. Mall's solution 
Glycerin ...............................• 20 ml 
Distilled water ••••••••••••••••••••.•••• 79 ml 
Potass. hydroxide •••••••••••••••••••.••• 1 gm 
1. Whole specimens are fixed in 95% alcohol for 
at least three days. 
2. Transfer to acetone and leave several days 
to dissolve out fats. 
3. Wash well with 95% alcohol; then immerse 
in 95% alcohol for 24 hours. 
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4. Immerse in Solution A from one to seven days, 
according to size of specimen, until the bones 
are clearly visible through the muscle. 
5. Transfer to Solution B until bones are stained 
the desired depth of color; this takes from 
one to seven days, and the solution should be 
changed on the 4th day. 
6. Clear in Solution C until no more color 
comes out. 
7. Pass into a mixture of equal parts of 
glycerin and water, and continue through 
increasing strengths of glycerin. 
8. Store in pure glycerin. 
The eighteen and nineteen day old pups fixed in 
Bouin's Fixative and sectioned according to Wilson (1965) 
were examined for gross physical characteristics but 
histological characteristics were not studied. Pups were 
examined for syndactyly, polydactyly, and adactyly, 
phocomelia, exopthalamus, anopthalamia, microphthalmia, 
hydrocephaly, exencephaly, cleft plate, heart chambers 
division, number and position of kidneys, development of 
esophagus, trachea, lungs, liver stomach and gonads and 
I 
other digestive organs. 
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The stained pups with Alizarin Red were examined 
for normal development and number of ribs, cervical, 
thoracic and sacral vertebrae, sternebrae as well as general 
skeletal bones of the palate, arm, legs, shoulder and pelvic 
areas. 
PHASE II - PRENATAL STUDY 
A dosage of 2000 mg/kg of amygdalin was chosen 
for this study because although it was a high dose it was 
still non-toxic to the adult female animal (Manner, DiSanti 
and Michalsen, 1977}. The procedure used for the experiment 
with this new dose was the same as the previous study except 
for 2 variations. 
VARIATION I 
The control group received .3cc of isotonic Lockes 
solution and the treated group received .3cc of amygdalin 
equivalent to 1000 mg/kg body weight into both right and 
left rear thighs daily. A concentrated mixture of amygdalin 
for one single injection of .3cc at 2000 mg/kg dose could 
not be obtained without the immediate occurrence of a 
precipitate. The dose of amygdalin was based on a 30 gm 
mouse and was equivable to 2000 mg/kg body weight. 
r 
2000 mg amygdalin 
1 kg body wt. 
= X gm amygdalin 
.03 kg mouse 
X = 60 mg amygdalin/injection 
= ·.o6 gm amygdalin/injection 
= X gm amygdalin 
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.06 gm amygdalin/injection 
.6cc injection volume 10 cc a2o (distilled-deionized) 
X = 1 gm 
thus, 1 gm of amygdalin was dissolved in lOcc of distilled-
deionized water and .Gee was equivalent to a 2000 rng/kg 
dose. The mouse could best accomodate intramuscular 
injections of .3cc into.both rear legs instead of giving 
one large injection of .6cc. Due to the small size of 
this strain of mice injections exceeding the volume of 
.4cc caused leakage from the site of injection. 
VARIATION II 
The mother mouse has been observed to eat her 
offspring when they were born dead or abnormal. Thus, 
precautions against maternal cannibalism were more closely 
controlled this time because the chances for abnormal 
development or death to the offspring would be expected 
to be greater at this higher dosage. The female's pregnancy 
was terminated after she had completed 18 full gestational 
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days by over-etherization. At this time she had received 
a total of 18 injections of amygdalin each at a dose of 
2000 mg/kg. The fetuses were removed from the uterus and 
recorded as living if movement was detected. Reabsorptions 
were recognized by underdeveloped embryos or yellow nodules 
(metria! glands), and were recorded. Fetuses were blotted, 
litter weights were taken, and average pup weights 
calculated. 
Procedures for examination of the fetuses were 
the same as in the previous study. Both external and 
internal development as well as skeletal formation were 
examined. 
RECORDS FOR PHASES I & II 
Litter sizes and weights, pup average sizes and 
anamolies were recorded for all groups studies. Photographs 
were taken of controls and 500 mg/kg and 2000 mg/kg 
amygdalin treated animals, for both Wilson's sectioning 
technique and the Alizarin Red skeletal staining. Means 
and standard deviations were calculated for pup and fetus 
weights and litter sizes. Student t-Tests were used to 
determine if there were statistical difference between 
the groups. 
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PHASE III - POSTNATAL STUDY 
There were 3 groups of treatment in this study, 
a control group, a group that received 500 mg/kg dose of 
amygdalin and a group that received 2000 mg/kg of amygdalin. 
The procedures for mating and administering the amygdalin 
were carried out in the same manner as Phases I and II. 
The females were permitted to carry their pregnancy full 
term. When the females gav·e birth the injections were 
stopped in all groups. The number of offspring were counted 
in every litter and returned to their mother to care for 
them the next three weeks. Daily examination of the litters 
were made to remove any pups that had died and to look 
for anamolies that could have been developing. At the 
end of the three week period the number of offspring were 
again counted in each litter and at the same time examined 
for physical or behavioral abnormalities that may be 
apparent. Student t-Tests were used to examine the data 
for statistical differences. 
RESULTS AND DISCUSSION 
Chronic doses of amygdalin were administered over 
the entire period the mouse was in gestation instead of 
only 3-4 days during periods of organogenesis as suggested 
by Wilson (1973). This teratogenic study attempts to 
simulate the same procedures that are employed in human 
clinical use of the agent. The reason for using these 
chronic doses is that patients on amygdalin therapy must 
remain on amygdalin for prolonged periods of time. Even 
after treatment appears successful or even if the cancer 
has been surgically removed, maintenance doses of amygdalin 
are recommended so that the total length of time of 
amygdalin administration can far exceed the nine month 
period of human gestation. If any adverse effects on the 
mouse fetuses would have been found in our study which 
can be attributed to chronic does of amygdalin, isolation 
of the particular stage of development affected by the 
administered amygdalin could be later on determined with 
further studies. 
Freehand razor blade sectioning by Wilson's 
te~hnique is reliable for most small species of test animals 
and histological serial sections are generally regarded 
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as impractical (Wilson, 1973). The specimen's fixation 
in Boulin's is advantageous because it causes less shrinkage 
of the specimen and because of its acidity it decalcifies 
bony structures within a week or two greatly facilitating 
the sectioning process (Wilson, 1965). 
Wilson's technique for examination of the fetuses 
is reliable for most physical defects (Wilson, 1965). 
Control groups played a great part in determining what 
was a normal condition in this teratogenic study of the 
mouse. However, since this is a less accurate method than 
histological techniques, Phase III study was conducted. 
Allowing the offspring to live for 3 weeks would make any 
defects that may bave been overlooked become apparent with 
growth of the animal. Also functional anomalies could 
be examined that many times are not investigated in 
teratogenic studies because they are too time consuming. 
The results (Tables I-V) from all three studies 
(Natal, Prenatal and Postnatal) indicate that there is 
no significant teratogenic effects on the mice offspring 
whose mothers have been treated with chronic doses of 
amygdalin. Statistical analysis on the litter sizes and 
average pup weights for the studies comparing controls 
with groups treated at 500 mg/kg and 2000 mg/kg, showed 
no significant differences. In a study comparing controls 


















m1ALE GESTATION PERIODS AND LI'.rl'ER SIZES 
A \'ERAGE PUP \·/EIGHTS 
GROUP II 
Af1YGDALIN TREATED m1ALES CONTROL 
(500 mg/kg) 
Gestation Total Average Gestation Total 
Period Litter Pup Female Period Litter 
Days Size Weight(g) No. Days Size 
19 6 1.25 1 19 6 
19 8 1.47 2 19 6 
20 9 1.34 3' 19 6 
20 6 1.30 4 19 8 
20 9 1.28 5 19 6 
20 5 1.21 6 19 7 
19 8 1.31 ? 19 7 
19 5 . 1 ... 39 8 20 9+ 
19 6 1.32 9 19 7 
20 8 1.18 10 19 4 
19 8 1.35 11 19 7 
19 10+• 1.26 12 19 8 
+ = 1 Pup born dead which is included in total litter size number. 

































FEMALE GESTATION PERIODS AND LITTER SIZES 
AVERAGE PUP \/EIGHTS 
GROUP III GROUP IV 
Af.IYGDALIN TREATED FEHALES CONTROL ( 2000 mg/kg) 
... .. 
Gestation Average Gestation 
Period Utter Pup Female Period Utter 
Day-s Size Weight(g) No. Day-s Size 
18 5*** 1.05 1 18 9 
18 8 1.17 2 18 4••• 
18 7 1.27 3 18 8 
18 7 1.12 4 18 9 
18 6 1.10 5 18 8 
18 8 1.01 
18 7 1.36 
18 8 1.20 
18 6 1.14 
18 8 1.12 
18 7* .83 














PERCENT DEATHS OR REABSORPTIONS FOR EACH GROUP 
Litter Pup 
GROUP Size \Ieight % Deaths % Reabsorptiona 
(g) 
. 
I 7.33 1.31 2.0 -----
500mg/kg ... 46 
-
+.02 
II 6.75· 1.32 1.0 -----
Control :!:·36 +.02 
III 7.00 1.12 0 5.0 
2000mg/kg !·29 +.04 
-
IV 7.60 1.15 0 7.0 











PERCENT OF OFFSPRING ALIVE 3 WEEKS AFTER BIRTH 
NO. of Pups NO. of Pups 96 ot Litter Born Alive Alive After 3 Weeks Alive After 3 Weeks 
4o 31 78 
27 21 78 











Prenatal Group IV 
Control 
Control 




Total NO. Offspring NO. of Offspring 








•<no.) • Number of animals having abnormality in that group 
Abnormal! ties • 
(l)Polydactyly-1 extra toe 
(l)Missing 1 13th rib 
(l)Missing 1 sternebrae, 1 cerv-
ical vertebrae, 2 13th ribs 
(2)Fused sternebrae 
(1)Halformed Kidney 






and one undeveloped embryo in the treated group do not 
have much significance when one considers the 86 and 80 
offspring, respectively, born alive. As indicated in Table 
III, observations on the number of reabsorptions were not 
accounted for in this study. An accurate assessment of 
reabsorptions could not be made because the females were 
not sacraficed and their uteruses examined. Rather it 
was felt that a somewhat generalized assessment for 
reabsorptions could be made by comparing litter sizes of 
the control and amygdalin treated groups as to whether 
there was_reduction in litter sizes due to the amygdalin. 
In the subsequent study comparing controls and 
a 2000 mg/kg group, (Table II), the number of reabsorptions 
were identified by careful examination of ±he females 
uterus. The percent of reabsorption was found about the 
same for both the control and treated groups. 
The incidence of teratogenic anomalies observed 
in controls, 500 mg/kg and 2000 mg/kg groups appears to 
indicate a lack of the effect of the administered amygdalin 
(Table V). One incident of polydactyly at a dose of 500 
mg/kg was that of one extra toe on one foot. This appears 
non-significant because toe malformations are common to 
this strain of mice according to Jackson Laboratories where 
this strain of mice were obtained. Only one malformed 
f 
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kidney was found in these first two studies and it occurred 
in a control group. 
All other malformations dealt with the mouse's 
skeleton. Wilson (1973) is of the opinion that there is 
a great deal of uncertainty in the interpretation of results 
due to the spontaneous occurrence of minor anatomical 
variations especially the skeleton. Most mammalian species 
have been studied and have found to have anatomical 
variations in the segmental patterns of the axial skeleton 
especially in the number and morphology of ribs, sternebrae, 
lower thoracic and lumbar vertebrae (Wilson, 1973). They 
have been attributed to genotype and to assorted 
environmental influences in mice. In untreated pregnant 
mice, rats, rabbits, hamsters, guinea pigs and rhesus 
monkeys it is estimated that these skeletal anomalies occur 
in 5-15% or more of their offspring (Wilson, 1973). In 
view of these findings the 2 offspring found to have 
skeletal anomalies out of all of the offspring examined 
having stained bones, from amygdalin treated females, 
demonstrates a 2% occurrence and this most likely can not 
be attributed to amygdalin treatment. 
Sex ratios in this study were approximately 1-1 
in controls as well as in all the treated groups. However, 
sex determination at the time of birth is often difficult 
and not extremely accurate due to their small size and 
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variation of speciment sizes within a litter. 
The result of a postnatal study {Table IV) involving 
the evaluation of behaviorial anomalies showed no 
significant difference between the percentage of total 
number of offspring alive in each group at the end of the 
3 week period between either the control or treated groups. 
Examination of the offspring that remained alive at the 
end of 3 weeks showed no evidence of any significant 
physical or behavioral effects that can be attributed to 
amygdalin treatment. 
At this time it seems appropriate to mention the 
other factors that may lend some error to the interpretation 
of the results. Those factors include insufficient number 
of animals, inappropriate species, interpretation of 
variations vs. ma1.formations and the time of the year the 
experiment was performed. The response to teratogenic 
treatments has been shown to vary quantitatively and 
qualitatively at different times of the year in mice {Green, 
1966). 
There has been an earlier teratogenic rat study 
of amygdalin. However these results have little 
significance since data was not available in regards to 
number of animals examined, the time or duration of 
treatment and whether the kidney abnormalities noted were 
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characteristic of that rat strain. 
This teratology study on mice was performed because 
any clinically used compound should be tested for its effect 
on the unborn that may be exposed to it during maternal 
treatment. Both Kreb's "cyanide theory" and Beard's 
trophoblast theory of cancer prompted the need for this 
investigation. For if truth exists in these theories, 
damage to the unborn could be a great risk for a pregnant 
mother on amygdalin therapy. The negative results found 
in this study are in no way designed to disprove one of 
these theories. What these results do tell is that when 
mice are given intramuscular injections of amygdalin either 
the amygdalin is completely non·-toxic to the embryo and 
fetus or due to maternal and/or placental factors amygdalin 
at dosages as high as 2000 mg/kg body weight does not reach 
the embryo or fetus in high enough concentrations to cause 
toxic effects. If the latter is true perhaps higher dosages 
could bring about teratogenic effects. But due to the 
difficulty of obtaining higher dosages of injectable volumes 
without denaturing the amygdalin, higher dosages were not 
studied. Multiple daily injections to acquire higher 
dosages could also be investigated but stress from many 
constant injections to a pregnant mouse may introduce new 
statistical variables. Much more important than the dosage 
might be an investigation into a different method of 
administering the amygdalin. Most of the human clinical 
administration of the amygdalin is parenterally which is 
why the intramuscular route was chosen for this study. 
However, some amygdalin studies seem to indicate toxicity 
in adult animals when given orally. Further teratological 




Amygdalin has been postulated as being selectively 
destructive to cancer cells by hydrogen cyanide poisoning 
with the control and release of the cyanide by specific 
enzyme actions. Cancer cells and trophoblast cells of 
pregnancy are often both described as undifferentiated 
cells. The potential of trophoblast destruction by the 
amygdalin was investigated in this study as well as toxicity 
to the developing embryo. Pregnant female mice were 
injected intramuscularly with amygdalin through her entire 
pregnancy. Dosages of 500 mg/kg body weight and 20no mg/kg 
body weight were administered. Sectioning and skeletal 
staining of the offspring from the treated females indicated 
no teratogenic effects were found that were attributed 
to the amygdalin. Litter sizes and average pup weights 
of the offspring comparing control and treated groups showed 
no significant difference. A postnatal study allowing 
the offspring from control and treated groups to live 3 
weeks further substantiated the non-teratogenic effects 
of amygdalin at dosages as high as 2000 mg/kg body weight, 
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